Intelligence coverage: 55%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

PAVM

PAVmed Inc.

$3.82Sep 29, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

PAVmed Inc. shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +450% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +450% YoY in Q2 FY2026

Pipeline evidence · 0d ago

PAVM's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on PAVM.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full PAVM earnings analysis

Reported figures for PAVmed Inc. — research only, not investment advice.

Revenue YoY
+450.0%

Latest Intelligence

Updated

What happened recently for PAVmed Inc. (PAVM) — events, not interpretation.

Event
Reported Q2 2026 revenue +450% YoY.
Also
Last session September 29, 2026 at $3.82.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

PAVmed Inc. (PAVM)

US equity research on AlphaOS

Investment Snapshot above is the primary AlphaOS analysis for PAVmed Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:
$30.50M
Revenue:
$3.00M

PAVM earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow PAVmed Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.